Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy.

× No keyword cloud information.

47 in total

Review 1. Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia.

Authors: J L Pool; R S Kirby
Journal: Int Urol Nephrol Date: 2001 Impact factor: 2.370

Review 2. Benign prostatic hyperplasia and its treatment.

Authors: J B Stimson; S D Fihn
Journal: J Gen Intern Med Date: 1990 Mar-Apr Impact factor: 5.128

3. Pathophysiology of benign prostatic hyperplasia in the aging male population.

Authors: Herbert Lepor
Journal: Rev Urol Date: 2005

4. Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations.

Authors: Claus G Roehrborn
Journal: Rev Urol Date: 2008

Review 5. Subtypes of functional alpha1-adrenoceptor.

Authors: James R Docherty
Journal: Cell Mol Life Sci Date: 2009-10-28 Impact factor: 9.261

Review 6. Alpha 1-blockers vs 5 alpha-reductase inhibitors in benign prostatic hyperplasia. A comparative review.

Authors: J T Andersen
Journal: Drugs Aging Date: 1995-05 Impact factor: 3.923

Review 7. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors: M I Wilde; A Fitton; E M Sorkin
Journal: Drugs Aging Date: 1993 May-Jun Impact factor: 3.923

Review 8. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors: M I Wilde; A Fitton; D McTavish
Journal: Drugs Date: 1993-03 Impact factor: 9.546

9. Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia.

Authors: K L Lo; M C K Chan; A Wong; S M Hou; C F Ng
Journal: Int Urol Nephrol Date: 2009-05-16 Impact factor: 2.370

10. Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.

Authors: F Lefèvre-Borg; S E O'Connor; H Schoemaker; P E Hicks; J Lechaire; E Gautier; F Pierre; C Pimoule; P Manoury; S Z Langer
Journal: Br J Pharmacol Date: 1993-08 Impact factor: 8.739